Latest News
CEO Foran discusses margin gains amid macro headwinds and regulatory pressures.
Via The Motley Fool · September 11, 2026
Tariff recoveries and cost cuts drive profitability amid weak housing demand and lower sales.
Via The Motley Fool · September 11, 2026
EBITDA losses narrowed 17% despite revenue decline as cost cuts accelerated.
Via The Motley Fool · September 11, 2026
Exxon is leaning into growth, but a significant portion of that growth will come from one place.
Via The Motley Fool · September 11, 2026
Tonix Pharmaceuticals (NASDAQ:TNXP) CEO Seth Lederman told attendees at the Cantor Healthcare Conference that the company’s near-term focus is the commercial launch of TONMYA, its FDA-approved treatment for fibromyalgia in adults, while it advances development programs in Lyme disease prevention and
Via MarketBeat · September 11, 2026
The auto resale platform received an enticing buyout offer.
Via The Motley Fool · September 11, 2026
The transaction was valued at $1.6 million.
Via The Motley Fool · September 11, 2026
XPH delivered 57% returns over one year but swung 31% lower at its worst. IXJ offers steadier performance with higher income and $4.2 billion in assets for easier trading.
Via The Motley Fool · September 11, 2026
TD Bank (TSX:TD) stock is a dividend hero that I wouldn't sell after the recent run.
Via The Motley Fool · September 11, 2026
AI agents from OpenAI attacked a software service called RubyGems in May, months before the hack on Hugging Face.
Via Benzinga · September 11, 2026
Apple (NASDAQ:AAPL) has a small dividend, but it's growing steadily. After a strong device showcase, perhaps the best spot for the shares is your TFSA.
Via The Motley Fool · September 11, 2026
CT REIT (TSX:CRT.UN) might be the retail REIT to buy as shares plunge and yields swell.
Via The Motley Fool · September 11, 2026
Editas Medicine (NASDAQ:EDIT) outlined its strategy as an in vivo gene-editing company and said it remains on track to dose patients this year in a clinical study of its lead program, EDIT-401, for lowering LDL cholesterol.
Speaking at the Cantor Healthcare Conference, President and Chief Executive
Via MarketBeat · September 11, 2026
CN Rail (TSX:CNR) may be the steadiest compounder on the entire Canadian stock market.
Via The Motley Fool · September 11, 2026
This transaction appears to be routine.
Via The Motley Fool · September 11, 2026
The tech giant has rebounded from its recent slump, but there may not be much near-term upside left.
Via The Motley Fool · September 11, 2026
This stock is down 15% from the recent highs and now offers an attractive dividend yield.
Via The Motley Fool · September 11, 2026
Snowflake surprised investors by delivering stronger-than-expected revenue growth.
Via The Motley Fool · September 11, 2026
Sales could accelerate for Qualcomm as early as its next fiscal year.
Via The Motley Fool · September 11, 2026
Meta Platforms has invested aggressively in artificial intelligence.
Via The Motley Fool · September 11, 2026
The foldable iPhone was announced to rave reviews.
Via The Motley Fool · September 11, 2026
Its customers appreciate the value as sales continue to increase.
Via The Motley Fool · September 11, 2026
Pinterest (NYSE:PINS) CEO Bill Ready said the company has evolved from a visual discovery and browsing platform into what he described as an AI-driven shopping assistant serving more than 640 million users. Speaking at a conference fireside chat, Ready said the company’s efforts to make the platform
Via MarketBeat · September 11, 2026
The management team has not yet found an effective strategy to counter increasing trade barriers in the U.S.
Via The Motley Fool · September 11, 2026
The strength of Corby’s domestic business has helped offset some of the potential weakness associated with U.S. exports.
Via The Motley Fool · September 11, 2026